MSN Labs gets CDSCO panel nod to manufacture, market Tofacitnib Oral Solution Dr. Divya Colin22 Jun 2023 4:40 PM ISTNew Delhi: Granting waivers for local clinical trials and bioavailability/bioequivalence (BA/BE) studies, the Subject Expert Committee (SEC)...
JAK inhibitors feasible treatment option for patients with Pyoderma gangrenosum Medha Baranwal1 Jun 2023 2:30 AM ISTBrazil: A recent study has stated that JAK inhibitors could be a potential alternative for treating pyoderma gangrenosum (PG) in certain patients,...
Tofacitinib tied to reduced incidence of ILD among Rheumatoid arthritis patients Aditi18 May 2023 8:00 PM ISTAn Original Investigation in Rheumatology published in JAMA Network Open has found a reduced risk of developing interstitial lung disease (ILD) in...
Decoding Safety and Efficacy of Generic Tofacitinib Tablets in Rheumatoid Arthritis: Indian Evidence Dr. Kamal Kant Kohli24 April 2023 10:15 AM ISTRheumatoid Arthritis (RA) is one of the most debilitating chronic autoimmune affecting joints leading to inflammation, pain, persistent synovitis,...
CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib Dr. Divya Colin25 Dec 2022 4:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Submit Safety Data with Subgroup Analysis of CT: CDSCO Panel Tells Akum Pharma on Tofacitinib Oral Solution Dr. Divya Colin26 Nov 2022 5:45 PM ISTNew Delhi: Regarding the proposal for manufacturing and marketing of anti-rheumatic drug Tofacitinib Oral Solution 1mg/ml, the Subject Expert...
Tofacitinib shows promise in scleroderma patients, researchers optimistic for next phase of study Dr. Kamal Kant Kohli18 Oct 2022 7:30 PM ISTSystemic sclerosis-or scleroderma that affects the skin and internal organs-is one of the rarest autoimmune diseases, affecting roughly 100,000 people...
Rate of infection with tofacitinib higher than TNF inhibitors among patients with RA Dr. Shravani Dali8 Aug 2022 10:00 AM ISTRates of infection with tofacitinib in rheumatoid arthritis are higher than with tumour necrosis factor (TNF) inhibitors according to a recent study...
Include more sites from govt hospitals: CDSCO panel tells Intas on Tofacitinib Ointment 2% CT study Dr. Divya Colin15 May 2022 12:30 PM ISTNew Delhi: Directing the pharma major Intas Pharma to include more study sites from government hospitals geographically distributed in the country,...
Health Bulletin 18/February/2022 Roshni Dhar18 Feb 2022 5:21 PM ISTHere are Top Health stories of the dayHacking: Anti-hijab tweet on doc's account Dr Shantanu R Prabhu, a pediatrician in Ujire, said in a...
Sun Pharma gets CDSCO nod to market Tofacitinib to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis Susmita Roy17 Feb 2022 4:20 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Oral tofacitinib helps in alopecia areata in children Dr. Nandita Mohan25 Dec 2021 4:05 PM ISTA recent study in the journal Pediatric Dermatology showed oral tofacitinib to be clinically effective and well-tolerated in the majority of pediatric...
